|Bid||28.25 x 1400|
|Ask||28.43 x 1100|
|Day's range||28.13 - 29.31|
|52-week range||18.72 - 31.97|
|Beta (5Y monthly)||0.91|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||09 Nov 2010|
|1y target est||34.29|
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bausch Health Companies is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Bausch (BHC) delivered earnings and revenue surprises of 12.26% and 2.54%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Bausch (BHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Every investor in Bausch Health Companies Inc. (NYSE:BHC) should be aware of the most powerful shareholder groups...